Regional specific groundwater arsenic levels and neuropsychological functioning: A cross-sectional study

International Journal of Environmental Health Research

Volumn 24, Issue 6, 2014, Pages 546-557

  Edwards, Melissa ^a   Johnson, Leigh ^b,c   Mauer, Cortney ^d   Barber, Robert ^a   Hall, James ^a   Obryant, Sid ^b,c  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b University of North Texas Health Science Center   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^d TEXAS TECH UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; arsenic; Groundwater; Mild cognitive impairment; Neuropsychology

Indexed keywords

ARSENIC; GROUND WATER; WATER POLLUTANT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GEOGRAPHIC INFORMATION SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; VERBAL MEMORY; ANALYSIS; MIDDLE AGED; UNITED STATES; VERY ELDERLY; WATER POLLUTANT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ARSENIC; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; GEOGRAPHIC INFORMATION SYSTEMS; GROUNDWATER; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; TEXAS; WATER POLLUTANTS, CHEMICAL;

EID: 84926116863     PISSN: 09603123     EISSN: 13691619     Source Type: Journal    
DOI: 10.1080/09603123.2014.883591     Document Type: Article

References (56)

1. Andersen O, Nielsen JB. 1994. Effects of simultaneous low level supplementation with inorganic and organic selenium on whole-body, blood and organ levels of toxic metals in mice. Environ Health Perspect. 102:321-324.
2. AvRuskin GA, Jacquez GM, Meliker JR, Slotnick MJ, Kaufmann AM, Nriagu JO. 2004. Visualization and exploratory analysis of epidemiologic data using a novel space time information system. Int J Health Geogr. 3:26.
3. Babiker IS, Mohamed MAA, Hiyama T. 2007. Assessing groundwater quality using GIS. Water Resour Manage. 21:699-715.
4. Baum L, Chan IHS, Cheung SKK, Goggins WB, Mok V, Lam L, Leung V, Hui E, Ng C, Woo J, et al. 2010. Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability. Biometals. 23:173-179.
5. Biswas S, Talukder G, Sharma A. 1999. Prevention of cytotoxic effects of arsenic by short-term dietary supplementation with selenium in mice in vivo. Mutat Res. 441:155-160.
6. Bolla-Wilson K, Bleecker ML. 1987. Neuropsychological impairment following inorganic arsenic exposure. J Occup Med. 29:500-503.
7. Darvesh AS, Carroll RT, Bishayee A, Geldenhuys WJ, Van der Schyf CJ. 2010. Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Rev Neurother. 10:729-745.
8. Dewji NN, Do C, Bayney RM. 1995. Transcriptional activation of Alzheimer's β-amyloid precursor protein gene by stress. Brain Res. Mol. Brain Res. 33:245-253.
9. Dho S, Camusso W, Mucciarelli M, Fusconi A. 2010. Arsenate toxicity on the apices of Pisum sativum L. seedling roots: effects on mitotic activity, chromatin integrity and microtubules. Environ Exp Bot. 69:17-23.
10. Engström KS, Vahter M, Johansson G, Lindh CH, Teichert F, Singh R, Kippler M, Nermell B, Raqib R, Strömberg U, Broberg K. 2010. Chronic exposure to cadmium and arsenic strongly influences concentrations of 8-oxo-7,8-dihydro-2'-deoxyguanosine in urine. Free Radic Biol Med. 48:1211-1217.
11. Fatmi Z, Azam I, Ahmed F, Kazi A, Gill AB, Kadir MM, Ahmed M, Ara N, Janjua NZ. 2009. Health burden of skin lesions at low arsenic exposure through groundwater in Pakistan. Is river the source? Environ Res. 109:575-581.
12. Focazio M, Welch AH, Watkins SA, Helsel DR, Horn MA. 2000. A retrospective analysis on the occurrence of arsenic in ground-water resources of the United States and limitations in drinking-water-supply characterizations; Water-Resources Investigations Report 99-4279. Washington (DC): U.S. Geological Survey.
13. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psych Res. 12:189-198.
14. Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, Luo M, Bhattacharya S, Kandjanapa K, Soontararuks S, Nookabkaew S, et al. 2007. Activation of inflammation/NF-κB signaling in infants born to arsenic-exposed mothers. PLoS Genet. 3:2180-2189.
15. Fytianos K, Christophoridis C. 2004. Nitrate, arsenic and chloride pollution of drinking water in northern Greece. Elaboration by applying GIS. Environ Monit Assess. 93:55-67.
16. Garelick H, Jones H, Dybowska A, Valsami-Jones E. 2008. Arsenic pollution sources. Rev Environ Contam Toxicol. 197:17-60.
17. Gong G, Hargrave KA, Hobson V, Spallholz J, Boylan M, Lefforge D, O'Bryant SE. 2011. Low-level groundwater arsenic exposure impacts cognition: a project FRONTIER study. J Environ Health. 74:16-22.
18. Gong G, O'Bryant SE. 2010. The arsenic exposure hypothesis for Alzheimer disease. Alzheimer Dis Assoc Disord. 24:311-316.
19. Grandjean P, Landrigan P. 2006. Developmental neurotoxicity of industrial chemicals. Lancet. 368:2167-2178.
20. Hobson VL, Hall JR, Harvey M, Cullum CM, Lacritz L, Massman PJ, Waring SC, O'Bryant SE. 2011. An examination of the Boston Naming Test: calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population. Int J Geriatr Psychiatry. 26:351-355.
21. Ivnik R, Malec JF, Smith GE, Tangalos EG, Petersen RC, Kokmen E, Kurkland LT. 1992. Mayo's older Americans normative studies: WAIS-R norms for age 56 to 97. The Clin Neuropsych. 6:1-30.
22. Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RC. 1996. Neuropsychological tests' norms above age 55: COWAT, BNT, MAE token, WRAT-R reading, AMNART, STROOP, TMT, and JLO. Clin Neuropsychol. 10:262-278.
23. Kapaj S, Peterson H, Liber K, Bhattacharya P. 2006. Human health effects from chronic arsenic poisoning-a review. J Environ Sci Health A Tox Hazard Subst Environ Eng. 41:2399-2428.
24. Khan NI, Owens G, Bruce D, Naidu R. 2009. Human arsenic exposure and risk assessment at the landscape level: a review. Environ Geochem Health. 31:143-166.
25. Lezak MD, Howieson DB, Loring DW. 2004. Neuropsychological assessment. 4th ed. Oxford: Oxford University Press.
26. Liao C, Shen HH, Chen CL, Hsu Li, Lin TL, Chen SC, Chen CJ. 2009. Risk assessment of arsenic-induced internal cancer at long-term low dose exposure. J. Hazard. Mater. 165: 652-663.
27. Luo JH, Qiu ZQ, Shu WQ, Zhang YY, Zhang L, Chen JA. 2009. Effects of arsenic exposure from drinking water on spatial memory, ultra-structures and NMDAR gene expression of hippocampus in rats. Toxicol Lett. 184:121-125.
28. Martinez-Finley EJ, Ali AMS, Allan AM. 2009. Learning deficits in C57BL/6J mice following perinatal arsenic exposure: consequence of lower corticosterone receptor levels? Pharmacol Biochem Behav. 94:271-277.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 34:939-939.
30. Meng D, Wang X, Chang Q, Hitron A, Zhang Z, Xu M, Chen G, Luo J, Jiang B, Fang J, Shi X. 2010. Arsenic promotes angiogenesis in vitro via a heme oxygenase-1-dependent mechanism. Toxicol Appl Pharmacol. 244:291-299.
31. Morris JC. 1993. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 43:2412-2412.
32. National Research Council. 1999. Subcommittee on arsenic in drinking water. Arsenic in drinking water. Washington, DC: National Academies Press.
33. National Research Council. 2001. Arsenic in drinking water: 2001 update. Washington, DC: The National Academies Press.
34. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. 2008. Arsenic exposure and prevalence of Type 2 diabetes in US adults. JAMA. 300:814-822.
35. O'Bryant S, Edwards M, Menon CV, Gong G, Barber R. 2011. Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a project FRONTIER study. Int J Environ Res Public Health. 8:861-874.
36. O'Bryant SE, Hobson V, Hall JR, Waring SC, Chan W, Massman P, Lacritz L, Cullum CM, Diaz-Arrastia R. 2009. Brain-derived neurotrophic factor levels in Alzheimer's disease. J Alzheimer's Dis. 17:337-341.
37. Petersen RC. 2003. Mild cognitive impairment: aging to Alzheimer's disease. New York (NY): Oxford University Press.
38. Rosado JL, Ronquillo D, Kordas K, Rojas O, Alatorre J, Lopez P, Garcia-Vargas G, del Carmen Caamaño M, Cebrián ME, Stoltzfus RJ. 2007. Arsenic Exposure and cognitive performance in Mexican school children. Environ Health Perspect. 115:1371-1375.
39. Samadder SR, Subbarao C. 2007. GIS approach of delineation and risk assessment of areas affected by arsenic pollution in drinking water. J Environl Eng. 133:742-749.
40. Strauss E, Sherman EMS, Spreen O. 2006. A compendium of neuropsychological tests: administration, norms, and commentary. 3rd ed. Oxford: Oxford University Press.
41. Su CC, Lin YY, Chang TK, Chiang CT, Chung JA, Hsu YY, Lian IB. 2010. Incidence of oral cancer in relation to nickel and arsenic concentrations in farm soils of patients' residential areas in Taiwan. BMC Public Health. 10:67.
42. Tan ZS, Seshadri S, Beiser A, Wilson PWF, Kiel DP, Tocco M, D'Agostino RB, Wolf PA. 2003. Plasma total cholesterol level as a risk factor for Alzheimer disease. Arch Intern Med. 163:1053-1057.
43. The Psychological Corporation. 1997. WAIS-III - WMS-III technical manual. San Antonio (TX): The Psychological Corporation.
44. Thies W, Bleiler L. 2013. 2013 Alzheimer's disease facts and figures Alzheimer's Association. Alzheimers Dement. 9:208-245.
45. Tsai SY, Chou HY, The HW, Chen CM, Chen CJ. 2003. The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. NeuroToxicology. 24:747-753.
46. Usali N, Ismail MH. 2010. Use of remote sensing and GIS in monitoring water quality. J Sustainable Dev. 3:228-238.
47. Vahidnia A, van der Straaten RJHM, Romijn F, van Pelt J, van der Voet GB, de Wolff FA. 2007. Arsenic metabolites affect expression of the neurofilament and tau genes: an in vitro study into the mechanism of arsenic neurotoxicity. Toxicology In Vitro. 21:1104-1112.
48. Vega L, Styblo M, Patterson R, Cullen W, Wang C, Germolec D. 2001. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol Appl Pharmacol. 172:225-232.
49. Wang Y, Li S, Piao F, Hong Y, Liu P, Zhao Y. 2009. Arsenic down-regulates the expression of Camk4, an important gene related to cerebellar LTD in mice. Neurotoxicol Teratol. 31: 318-322.
50. Waring S, O'Bryant SE, Reisch JS, Diaz-Arrastia R, Knebl J, Doody R, for the Texas Alzheimer's Research Consortium. 2008. The Texas Alzheimer's research consortium longitudinal research cohort: study design and baseline characteristics. Texas Public Health J. 60:9-13.
51. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, Slavkovich V, LoIacono NJ, Cheng Z, Hussain I, et al. 2004. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspects. 112:1329-1333.
52. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, Kline J, van Geen A, Slavkovich V, Lolacono NJ, Levy D, et al. 2007. Water arsenic exposure and intellectual function in 6-yearold children in Araihazar. Bangladesh Environ Health Perspect. 115:285-289.
53. Wechsler D. 1997. Wechsler memory scale third edition manual. San Antonio (TX): The Psychological Corporation.
54. Wright RO, Amarasiriwardena C, Woolf AD, Jim R, Bellinger DC. 2006. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. NeuroToxicology. 27:210-216.
55. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. 1983. Development and validation of a geriatric depression screening scale: a preliminary report. J Psych Res. 17:37-49.
56. Yin X, Wright J, Wall T, Grammas P. 2010. Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease. Am J Pathol. 176:1600-1606.